Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity

CMAJ. Canadian Medical Association Journal

Volumn 171, Issue 5, 2004, Pages 466-472

  Pépin, Jacques ^a,b   Valiquette, Louis ^a   Alary, Marie Eve ^a   Villemure, Philippe ^a   Pelletier, Anick ^a   Forget, Karine ^a   Pépin, Karine ^a   Chouinard, Daniel ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE FACTOR; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; CANADA; CHILD; CLOSTRIDIUM DIFFICILE; COLON PERFORATION; COLON RESECTION; COMPUTER; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; CYTOTOXICITY; DATA BASE; DEATH; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HOSPITAL; HUMAN; INCIDENCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEGACOLON; PSEUDOMEMBRANOUS COLITIS; REVIEW; SHOCK;

EID: 4444382260     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: 10.1503/cmaj.1041104     Document Type: Review

References (30)

1. Barbut F, Corthier G, Charpak Y, Cerf M, Monteil H, Fosse T, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients. A French multicenter study. Arch Intern Med 1996;156:1449-54.
2. Kelly CP, LaMont JT. Clostridium difficile infection. Annu Rev Med 1998;49:375-90.
3. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998;16:292-307.
4. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997;92:739-50.
5. Johnson SJ, Gerding DN. Clostridium difficile-associated diarrhea. Clin Infect Dis 1998;26:1027-36.
6. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
7. Hirschborn LR, Trnka Y, Onderdonk A, Lee MLT, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis 1994;169:127-33.
8. Frost F, Hurley JS, Petersen HV, Casciano RN. Estimated incidence of Clostridium difficile infection. Emerg Infect Dis 1999;5:302-3.
9. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile Study Group. Clin Infect Dis 1998;26(1):141-5.
10. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis. An increasingly aggressive iatrogenic disease? Arch Surg 2002;137:1096-100.
11. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72.
12. Staneck JL, Weckbach LS, Allen SD, Siders JA, Gilligan PH, Coppitt G, et al. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard for C. difficile, cytotoxin assay, culture and latex agglutination. J Clin Microbiol 1996;34:2718-21.
13. Nombre d'hospitalisations, durée de séjour et séjour moyen, en soins de courte durée actifs selon le sexe et la phase de vie, 1992-1993 et 2001-2002. Québec: Ministère de la Santé et des Services Sociaux du Québec. Available: www.msss.gouv.qc.ca/ statistiques/produc_util.html (accessed July 2004).
14. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390-7.
15. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect 1998;40:1-15.
16. Thielman NM. Antibiotic-associated colitis. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 5th ed. Philadephia: Churchill Livingstone; 2000. p. 1111-26.
17. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Morb Mortal Wkly Rep 1995;44(RR-12):1-13.
18. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334-9.
19. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J. Clostridium difficile associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459-77.
20. Hogenauer C, Hammer HF, Krejs GJ, Reisinger EC. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 1998;27:702-10.
21. Poutanen SM, Simor AE. Clostridium difficile-associated diarrhea in adults. CMAJ 2004;171(1):51-8.
22. Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, et al. Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983;2:1043-6.
23. Wenisch C, Parschalf B, Haselhundl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996;22:813-8.
24. Bartlett J. Clostridium difficile: clinical considerations. Rev Infect Dis 1990;12(Suppl 2):S243-51.
25. Wilcox MH, Spencer RC. Clostridium difficile infection: responses, relapses and re-infections. J Hosp Infect 1992;22:85-92.
26. Olson MM, Shanholtzer CJ, Lee JT, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991. Infect Control Hosp Epidemiol 1994;15:371-81.
27. Khan F, Cheesbrough J. Impact of changes in antibiotic policy on Clostridium difficile-associated diarrhoea (CDAD) over a five year period in a district general hospital. J Hosp Infect 2003;54:104-8.
28. Gerding DN. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: This is an antimicrobial resistance problem. Clin Infect Dis 2004;38:646-8.
29. Gorbach SL. Antibiotics and Clostridium difficile. N Engl J Med 1999;341:1690-1.
30. Gaynes R, Rimland D, Killum E, Lowery K, Johnson TM, Killgore G, et al. Outbreak of Clostridium difficile infection in a long term care facility: association with gatifloxacin use. Clin Infect Dis 2004;38:640-5.